Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05800821Recruiting

Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning

Role: lead

NCT07159698Enrolling By Invitation

Clinical Profile of a Patient After MI and ACVA Based on Outpatient Register Data

Role: lead

NCT06815913Active Not Recruiting

To Develop and Introduce Into Polyclinic Practice a Register of Patients with Experience of Myocardial Infarction and Acute Cerebrovascular Disease

Role: lead

NCT04588935Phase 2Completed

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

Role: lead

All 4 trials loaded